
    
      PROTOCOL OUTLINE: Patients receive oral cholic acid and oral chenodeoxycholic acid on day 1.
      On day 4, patients receive oral cholic and ursodeoxycholic acids. Patients are assessed at 3
      and 6 months for liver function response, neurologic status, and nutritional status.

      Patients receive treatment until disease progression or unacceptable toxic effects are
      observed.

      Completion date provided represents the completion date of the grant per OOPD records
    
  